Cage Pharma, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Cage Pharma, Inc. - overview
Location
Baltimore, MD, US
Primary Industry
Biotechnology
About
Based in Maryland, US, Cage Pharma, Inc. operates as a preclinical biopharmaceutical company that focuses on the development and research of healthcare solutions. In May 2024, the firm raised USD 137,490 in venture funding from investors. Cage Pharma engages in creating novel pharmaceutical products targeting a range of diseases and medical conditions.
The company's portfolio includes both preclinical and clinical-stage drug candidates, with a focus on developing therapies that offer improvements over existing treatments. Cage Pharma's approach involves leveraging technologies and rigorous scientific research to drive innovation in drug development.
Current Investors
Catalio Capital Management
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Specialty Pharmaceuticals
Website
www.cagephar.ma/
Total Amount Raised
Subscriber access only
Cage Pharma, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | Cage Pharma, Inc. | - |
Displaying 1 - 1 of 1
Cage Pharma, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.